Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

An international cancer study has found that exercise can have huge benefits for cancer patients and can even reduce the risk ...

In addition, the study's results suggested a substantial overall survival (OS) benefit with the exercise regimen as well, ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...

AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of ...

Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

Oncology biosimilars significantly reduce financial toxicity in cancer care, as highlighted in 2 abstracts presented at the ...